CytoMed Therapeutics Limited Is Accelerating Its International Expansion – Cloud PR Wire
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
CytoMed Therapeutics Limited is accelerating its international expansion – Chicago Headlines
CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or the “Company”), a Singapore-based clinical stage biopharmaceutical company focused on harnessing its proprietary technologies to develop novel affordable donor-derived cell-based immunotherapies for the treatment of a broad range of cancers, including both blood and solid tumors, The company announced that its wholly-owned subsidiary established in 2020, Advance Cancer Centre Pte. Ltd.,…
CytoMed Therapeutics Limited is accelerating its international expansion – Cloud PR Wire
CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or the “Company”), a Singapore-based clinical stage biopharmaceutical company focused on harnessing its proprietary technologies to develop novel affordable donor-derived cell-based immunotherapies for the treatment of a broad range of cancers, including both blood and solid tumors, The company announced that its wholly-owned subsidiary established in 2020, Advance Cancer Centre Pte. Ltd.,…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
